Risen Pharma Announces Initiation of Phase 2 Clinical Trial of RP902 for Mild Cognitive Impairment Due to Alzheimer’s Disease
SHANGHAI, May 19, 2026 (GLOBE NEWSWIRE) — Risen Pharma, a clinical-stage biotech company focusing on the development and commercialization of high-need, patient-accessible therapeutics, today announced
Risen Pharma Announces Initiation of Phase 2 Clinical Trial of RP902 for Mild Cognitive Impairment Due to Alzheimer’s Disease
SHANGHAI, May 19, 2026 (GLOBE NEWSWIRE) — Risen Pharma, a clinical-stage biotech company focusing on the development and commercialization of high-need, patient-accessible therapeutics, today announced
Telefónica Germany Migrates 4G/5G Voice Services of First 100K Customers to Mavenir Cloud-Native IMS Technology
Milestone Move to IMS on AWS Achieved as Operator Transitions Fixed and Mobile Subscriber Base to Mavenir’s Web-Scale IMS Solution RICHARDSON, Texas, May 18, 2026
Telefónica Germany Migrates 4G/5G Voice Services of First 100K Customers to Mavenir Cloud-Native IMS Technology
Milestone Move to IMS on AWS Achieved as Operator Transitions Fixed and Mobile Subscriber Base to Mavenir’s Web-Scale IMS Solution RICHARDSON, Texas, May 18, 2026
CGTN: Head-of-state diplomacy anchors growing China-Russia partnership
Ahead of Russian President Vladimir Putin’s visit to China from May 19 to 20, CGTN has published an article examining the evolution of China-Russia relations
Quest Software Extends Data and AI Leadership with Quest Data Modeler and Quest Data Intelligence, Enhancing its Trusted Data Management Platform
New capabilities deliver cloud-native modeling, AI-powered policy management, and an expanded library of QuestAI assistants, giving modern data teams a single, governed foundation for analytics